spacer

GO Term History: Displaying 56 audit records for all terms for the date 2004-02-06

From (YYYY-MM-DD):
To (YYYY-MM-DD):
Period:
Category:
Terms:
Limit:
Date Specification

You can specify an explicit date range that you are interested in by setting the "From" and "To" parameters; this will limit the data displayed to those changes that were recorded within that (inclusive) date range.

Alternatively, you can use the "Period" parameter to view the GO term changes that occurred over a specific number of Day(s), Week(s), Month(s) or Year(s) before a specified date.

If you do not enter a "To" date, then the period will be relative to the current date. If, however, you do specify a "To" value, then the "Period" value will display records in the timeframe up to and including that specified date.

Category

You can use this field to specify what types of term changes you are interested in seeing.

Terms

You can enter a list of GO Terms in this field to limit the changes displayed. Please note that only changes made to directly listed terms will be displayed, not term descendants.

Limit

The default number of records returned is 500, however you can increase or decrease this limit. In order to prevent possible browser problems, the maximum upper limit is 10,000.

Introduction

This page displays the differences recorded in the full Gene Ontology OBO v1.2 file as audited by the UniProt-GOA database during its daily update cycle.
If there is any delay in uploading the current OBO file, the changes displayed and the date recorded for these changes may not correspond to when the changes to the OBO file were committed.

All changes

Timestamp GO ID GO Term Name Action Category Detail
2004-02-06 GO:0006238 CMP salvage Deleted SYNONYM CMP salvage
2004-02-06 GO:0006239 dCMP salvage Deleted SYNONYM dCMP salvage
2004-02-06 GO:0001806 type IV hypersensitivity Added SYNONYM delayed hypersensitivity response
2004-02-06 GO:0006238 CMP salvage Added SYNONYM cytidine monophosphate salvage
2004-02-06 GO:0006239 dCMP salvage Added SYNONYM deoxycytidine monophosphate salvage
2004-02-06 GO:0019492 proline salvage Added SYNONYM proline cycling
2004-02-06 GO:0001806 type IV hypersensitivity Added SECONDARY GO:0016069 (delayed hypersensitivity response)
2004-02-06 GO:0043099 pyrimidine deoxyribonucleoside salvage Added DEFINITION Any process that generates a pyrimidine deoxyribonucleoside from deriviatives of it, without de novo synthesis.
2004-02-06 GO:0010139 pyrimidine deoxyribonucleotide salvage Updated DEFINITION The pathway by which pyrimidine bases or pyrimidine deoxyribonucleotides from pyrimidine nucleotide breakdown are converted back to pyrimidine deoxyribonucleotides. The salvage pathway is important where there is no de novo pyrimidine deoxyribonucleotide biosynthesis.
2004-02-06 GO:0001778 plasma membrane repair Updated DEFINITION The resealing of a cell plasma membrane after cellular wounding due to, for instance, mechanical stress.
2004-02-06 GO:0016069 delayed hypersensitivity response Deleted DEFINITION A cell-mediated response that occurs in immune individuals peaking at 24-48 hours after challenging with the same antigen used in an initial challenge.
2004-02-06 GO:0043095 regulation of GTP cyclohydrolase I activity Deleted DEFINITION Any process which produces a carbon compound from deriviatives of it, without de novo synthesis.
2004-02-06 GO:0010140 adenine, hypoxanthine and their nucleoside salvage Updated DEFINITION OBSOLETE. The pathway by which adenine, hypoxanthine and their nucleosides from purine nucleotides breakdown are converted back to purine nucleotides. The salvage pathway is important where there is no de-novo purine nucleotide biosynthesis.
2004-02-06 GO:0043102 amino acid salvage Added DEFINITION Any process which produces an amino acid from deriviatives of it, without de novo synthesis.
2004-02-06 GO:0035095 behavioral response to nicotine Added DEFINITION A change in the behavior of an organism as a result of the perception of nicotine [(S)(-)-3-(1-methyl-2-pyrrolidinyl)pyridine].
2004-02-06 GO:0030877 beta-catenin destruction complex Updated DEFINITION A cytoplasmic protein complex containing glycogen synthase kinase-3-beta (GSK-3-beta), the adenomatous polyposis coli protein (APC), and the scaffolding protein axin, among others; phosphorylates beta-catenin, targets it for degradation by the proteasome.
2004-02-06 GO:0006236 cytidine salvage Added DEFINITION Any process that generates cytidine, cytosine riboside, from deriviatives of it without de novo synthesis.
2004-02-06 GO:0006239 dCMP salvage Added DEFINITION Any process that generates dCMP, deoxycytidine monophosphate from deriviatives of it, without de novo synthesis.
2004-02-06 GO:0006237 deoxycytidine salvage Added DEFINITION Any process that generates deoxycytidine, 2-deoxyribosylcytosine, from deriviatives of it, without de novo synthesis.
2004-02-06 GO:0001789 G-protein coupled receptor signaling pathway, coupled to S1P second messenger Updated DEFINITION A G-protein coupled signaling pathway that results in the activation of sphingosine kinase, causing an increase in cellular levels of sphingosine-1-phosphate.
2004-02-06 GO:0010141 guanine, xanthine and their nucleoside salvage Updated DEFINITION OBSOLETE. The pathway by which guanine, xanthine and their nucleoside from purine nucleotides breakdown are converted back to purine nucleotides. The pathway is important in cells where there is no de-novo purine nucleotides biosynthesis.
2004-02-06 GO:0019764 high affinity Fc receptor activity Updated DEFINITION OBSOLETE. (was not defined before being made obsolete).
2004-02-06 GO:0001821 histamine secretion Added DEFINITION The regulated release of histamine by a cell.
2004-02-06 GO:0043103 hypoxanthine salvage Added DEFINITION Any process that generates hypoxanthine, 6-hydroxy purine, from deriviatives of it without de novo synthesis.
2004-02-06 GO:0035061 interchromatin granule Updated DEFINITION A class of nuclear body measuring 20-25 nm in diameter and distributed throughout the interchromatin space, linked together by thin fibrils. They are believed to be storage centers for various snRNAs, snRNPs, serine/arginine-rich proteins and RNA polymerase II. A typical mammalian cell contains 25-50 clusters of interchromatin granules. Interchromatin granule clusters do not contain the heterogeneous nuclear RNA-binding proteins (hnRNPs).
2004-02-06 GO:0019358 nicotinate nucleotide salvage Updated DEFINITION The generation of nicotinate nucleotide without de novo synthesis.
2004-02-06 GO:0043097 pyrimidine nucleoside salvage Added DEFINITION Any process that generates a pyrimidine nucleoside, one of a family of organic molecules consisting of a pyrimidine base covalently bonded to a sugar ribose, from deriviatives of it, without de novo synthesis.
2004-02-06 GO:0008655 pyrimidine-containing compound salvage Added DEFINITION Any process that generates a pyrimidine, any nucleobase, nucleoside, nucleotide or nucleic acid that contains a pyrimidine base, from deriviatives of them without de novo synthesis.
2004-02-06 GO:0035094 response to nicotine Added DEFINITION A change in the state or activity of a cell or an organism as a result of the perception of nicotine [(S)(-)-3-(1-methyl-2-pyrrolidinyl)pyridine]; an addictive alkaloid extractable from the dried leaves of various species of tobacco, which is toxic to many animals.
2004-02-06 GO:0048155 S100 alpha binding Updated DEFINITION Interacting selectively with S100 alpha protein. S100 is a small calcium and zinc binding protein produced in astrocytes that is implicated in Alzheimer's disease, Down Syndrome and ALS.
2004-02-06 GO:0048153 S100 alpha biosynthetic process Updated DEFINITION The formation from simpler components of S100 alpha protein. S100 is a small calcium and zinc binding protein produced in astrocytes that is implicated in Alzheimer's disease, Down Syndrome and ALS.
2004-02-06 GO:0048154 S100 beta binding Updated DEFINITION Interacting selectively with S100 beta protein. S100 is a small calcium and zinc binding protein produced in astrocytes that is implicated in Alzheimer's disease, Down Syndrome and ALS.
2004-02-06 GO:0048152 S100 beta biosynthetic process Updated DEFINITION The formation from simpler components of S100 beta protein. S100 is a small calcium and zinc binding protein produced in astrocytes that is implicated in Alzheimer's disease, Down Syndrome and ALS.
2004-02-06 GO:0001820 serotonin secretion Added DEFINITION The regulated release of serotonin by a cell.
2004-02-06 GO:0048156 tau protein binding Updated DEFINITION Interacting selectively with tau protein. tau is a microtubule-associated protein, implicated in Alzheimer's disease, Down Syndrome and ALS.
2004-02-06 GO:0006223 uracil salvage Added DEFINITION Any process that generates uracil, 2,4-dioxopyrimidine, from deriviatives of it without de novo synthesis.
2004-02-06 GO:0001792 polymeric immunoglobulin receptor activity Updated DEFINITION Combining with a J-chain-containing polymeric immunoglobulin of the IGA or IGM isotypes via the Fc region to initiate a change in cell activity.
2004-02-06 GO:0019492 proline salvage Added DEFINITION Any process which produces the amino acid proline from deriviatives of it, without de novo synthesis.
2004-02-06 GO:0043101 purine-containing compound salvage Added DEFINITION Any process that generates a purine, any nucleobase, nucleoside, nucleotide or nucleic acid that contains a purine base, from deriviatives of them without de novo synthesis.
2004-02-06 GO:0019365 pyridine nucleotide salvage Updated DEFINITION Any process that generates a pyridine nucleotide, a nucleotide characterized by a pyridine derivative as a nitrogen base, from deriviatives of them without de novo synthesis.
2004-02-06 GO:0009443 pyridoxal 5'-phosphate salvage Added DEFINITION Any process that generates pyridoxal 5'-phosphate, the active form of vitamin B6, from deriviatives of it without de novo synthesis.
2004-02-06 GO:0043100 pyrimidine nucleobase salvage Added DEFINITION Any process that generates pyrimidine bases, 1,3-diazine organic nitrogenous bases, from deriviatives of them without de novo synthesis.
2004-02-06 GO:0006238 CMP salvage Updated TERM CMP salvage
2004-02-06 GO:0006239 dCMP salvage Updated TERM dCMP salvage
2004-02-06 GO:0001820 serotonin secretion Added TERM serotonin secretion
2004-02-06 GO:0001821 histamine secretion Added TERM histamine secretion
2004-02-06 GO:0016069 delayed hypersensitivity response Deleted TERM delayed hypersensitivity response
2004-02-06 GO:0035094 response to nicotine Added TERM response to nicotine
2004-02-06 GO:0035095 behavioral response to nicotine Added TERM behavioral response to nicotine
2004-02-06 GO:0019492 proline salvage Updated TERM proline salvage
2004-02-06 GO:0043095 regulation of GTP cyclohydrolase I activity Deleted TERM carbon compound salvage
2004-02-06 GO:0043099 pyrimidine deoxyribonucleoside salvage Added TERM pyrimidine deoxyribonucleoside salvage
2004-02-06 GO:0043100 pyrimidine nucleobase salvage Added TERM pyrimidine base salvage
2004-02-06 GO:0043101 purine-containing compound salvage Added TERM purine salvage
2004-02-06 GO:0043102 amino acid salvage Added TERM amino acid salvage
2004-02-06 GO:0043103 hypoxanthine salvage Added TERM hypoxanthine salvage

Terms

Timestamp GO ID GO Term Name Action Category Detail
2004-02-06 GO:0006238 CMP salvage Updated TERM CMP salvage
2004-02-06 GO:0006239 dCMP salvage Updated TERM dCMP salvage
2004-02-06 GO:0001820 serotonin secretion Added TERM serotonin secretion
2004-02-06 GO:0001821 histamine secretion Added TERM histamine secretion
2004-02-06 GO:0016069 delayed hypersensitivity response Deleted TERM delayed hypersensitivity response
2004-02-06 GO:0035094 response to nicotine Added TERM response to nicotine
2004-02-06 GO:0035095 behavioral response to nicotine Added TERM behavioral response to nicotine
2004-02-06 GO:0019492 proline salvage Updated TERM proline salvage
2004-02-06 GO:0043095 regulation of GTP cyclohydrolase I activity Deleted TERM carbon compound salvage
2004-02-06 GO:0043099 pyrimidine deoxyribonucleoside salvage Added TERM pyrimidine deoxyribonucleoside salvage
2004-02-06 GO:0043100 pyrimidine nucleobase salvage Added TERM pyrimidine base salvage
2004-02-06 GO:0043101 purine-containing compound salvage Added TERM purine salvage
2004-02-06 GO:0043102 amino acid salvage Added TERM amino acid salvage
2004-02-06 GO:0043103 hypoxanthine salvage Added TERM hypoxanthine salvage

Definition/synonyms

Timestamp GO ID GO Term Name Action Category Detail
2004-02-06 GO:0006238 CMP salvage Deleted SYNONYM CMP salvage
2004-02-06 GO:0006239 dCMP salvage Deleted SYNONYM dCMP salvage
2004-02-06 GO:0001806 type IV hypersensitivity Added SYNONYM delayed hypersensitivity response
2004-02-06 GO:0006238 CMP salvage Added SYNONYM cytidine monophosphate salvage
2004-02-06 GO:0006239 dCMP salvage Added SYNONYM deoxycytidine monophosphate salvage
2004-02-06 GO:0019492 proline salvage Added SYNONYM proline cycling
2004-02-06 GO:0043099 pyrimidine deoxyribonucleoside salvage Added DEFINITION Any process that generates a pyrimidine deoxyribonucleoside from deriviatives of it, without de novo synthesis.
2004-02-06 GO:0010139 pyrimidine deoxyribonucleotide salvage Updated DEFINITION The pathway by which pyrimidine bases or pyrimidine deoxyribonucleotides from pyrimidine nucleotide breakdown are converted back to pyrimidine deoxyribonucleotides. The salvage pathway is important where there is no de novo pyrimidine deoxyribonucleotide biosynthesis.
2004-02-06 GO:0001778 plasma membrane repair Updated DEFINITION The resealing of a cell plasma membrane after cellular wounding due to, for instance, mechanical stress.
2004-02-06 GO:0016069 delayed hypersensitivity response Deleted DEFINITION A cell-mediated response that occurs in immune individuals peaking at 24-48 hours after challenging with the same antigen used in an initial challenge.
2004-02-06 GO:0043095 regulation of GTP cyclohydrolase I activity Deleted DEFINITION Any process which produces a carbon compound from deriviatives of it, without de novo synthesis.
2004-02-06 GO:0010140 adenine, hypoxanthine and their nucleoside salvage Updated DEFINITION OBSOLETE. The pathway by which adenine, hypoxanthine and their nucleosides from purine nucleotides breakdown are converted back to purine nucleotides. The salvage pathway is important where there is no de-novo purine nucleotide biosynthesis.
2004-02-06 GO:0043102 amino acid salvage Added DEFINITION Any process which produces an amino acid from deriviatives of it, without de novo synthesis.
2004-02-06 GO:0035095 behavioral response to nicotine Added DEFINITION A change in the behavior of an organism as a result of the perception of nicotine [(S)(-)-3-(1-methyl-2-pyrrolidinyl)pyridine].
2004-02-06 GO:0030877 beta-catenin destruction complex Updated DEFINITION A cytoplasmic protein complex containing glycogen synthase kinase-3-beta (GSK-3-beta), the adenomatous polyposis coli protein (APC), and the scaffolding protein axin, among others; phosphorylates beta-catenin, targets it for degradation by the proteasome.
2004-02-06 GO:0006236 cytidine salvage Added DEFINITION Any process that generates cytidine, cytosine riboside, from deriviatives of it without de novo synthesis.
2004-02-06 GO:0006239 dCMP salvage Added DEFINITION Any process that generates dCMP, deoxycytidine monophosphate from deriviatives of it, without de novo synthesis.
2004-02-06 GO:0006237 deoxycytidine salvage Added DEFINITION Any process that generates deoxycytidine, 2-deoxyribosylcytosine, from deriviatives of it, without de novo synthesis.
2004-02-06 GO:0001789 G-protein coupled receptor signaling pathway, coupled to S1P second messenger Updated DEFINITION A G-protein coupled signaling pathway that results in the activation of sphingosine kinase, causing an increase in cellular levels of sphingosine-1-phosphate.
2004-02-06 GO:0010141 guanine, xanthine and their nucleoside salvage Updated DEFINITION OBSOLETE. The pathway by which guanine, xanthine and their nucleoside from purine nucleotides breakdown are converted back to purine nucleotides. The pathway is important in cells where there is no de-novo purine nucleotides biosynthesis.
2004-02-06 GO:0019764 high affinity Fc receptor activity Updated DEFINITION OBSOLETE. (was not defined before being made obsolete).
2004-02-06 GO:0001821 histamine secretion Added DEFINITION The regulated release of histamine by a cell.
2004-02-06 GO:0043103 hypoxanthine salvage Added DEFINITION Any process that generates hypoxanthine, 6-hydroxy purine, from deriviatives of it without de novo synthesis.
2004-02-06 GO:0035061 interchromatin granule Updated DEFINITION A class of nuclear body measuring 20-25 nm in diameter and distributed throughout the interchromatin space, linked together by thin fibrils. They are believed to be storage centers for various snRNAs, snRNPs, serine/arginine-rich proteins and RNA polymerase II. A typical mammalian cell contains 25-50 clusters of interchromatin granules. Interchromatin granule clusters do not contain the heterogeneous nuclear RNA-binding proteins (hnRNPs).
2004-02-06 GO:0019358 nicotinate nucleotide salvage Updated DEFINITION The generation of nicotinate nucleotide without de novo synthesis.
2004-02-06 GO:0043097 pyrimidine nucleoside salvage Added DEFINITION Any process that generates a pyrimidine nucleoside, one of a family of organic molecules consisting of a pyrimidine base covalently bonded to a sugar ribose, from deriviatives of it, without de novo synthesis.
2004-02-06 GO:0008655 pyrimidine-containing compound salvage Added DEFINITION Any process that generates a pyrimidine, any nucleobase, nucleoside, nucleotide or nucleic acid that contains a pyrimidine base, from deriviatives of them without de novo synthesis.
2004-02-06 GO:0035094 response to nicotine Added DEFINITION A change in the state or activity of a cell or an organism as a result of the perception of nicotine [(S)(-)-3-(1-methyl-2-pyrrolidinyl)pyridine]; an addictive alkaloid extractable from the dried leaves of various species of tobacco, which is toxic to many animals.
2004-02-06 GO:0048155 S100 alpha binding Updated DEFINITION Interacting selectively with S100 alpha protein. S100 is a small calcium and zinc binding protein produced in astrocytes that is implicated in Alzheimer's disease, Down Syndrome and ALS.
2004-02-06 GO:0048153 S100 alpha biosynthetic process Updated DEFINITION The formation from simpler components of S100 alpha protein. S100 is a small calcium and zinc binding protein produced in astrocytes that is implicated in Alzheimer's disease, Down Syndrome and ALS.
2004-02-06 GO:0048154 S100 beta binding Updated DEFINITION Interacting selectively with S100 beta protein. S100 is a small calcium and zinc binding protein produced in astrocytes that is implicated in Alzheimer's disease, Down Syndrome and ALS.
2004-02-06 GO:0048152 S100 beta biosynthetic process Updated DEFINITION The formation from simpler components of S100 beta protein. S100 is a small calcium and zinc binding protein produced in astrocytes that is implicated in Alzheimer's disease, Down Syndrome and ALS.
2004-02-06 GO:0001820 serotonin secretion Added DEFINITION The regulated release of serotonin by a cell.
2004-02-06 GO:0048156 tau protein binding Updated DEFINITION Interacting selectively with tau protein. tau is a microtubule-associated protein, implicated in Alzheimer's disease, Down Syndrome and ALS.
2004-02-06 GO:0006223 uracil salvage Added DEFINITION Any process that generates uracil, 2,4-dioxopyrimidine, from deriviatives of it without de novo synthesis.
2004-02-06 GO:0001792 polymeric immunoglobulin receptor activity Updated DEFINITION Combining with a J-chain-containing polymeric immunoglobulin of the IGA or IGM isotypes via the Fc region to initiate a change in cell activity.
2004-02-06 GO:0019492 proline salvage Added DEFINITION Any process which produces the amino acid proline from deriviatives of it, without de novo synthesis.
2004-02-06 GO:0043101 purine-containing compound salvage Added DEFINITION Any process that generates a purine, any nucleobase, nucleoside, nucleotide or nucleic acid that contains a purine base, from deriviatives of them without de novo synthesis.
2004-02-06 GO:0019365 pyridine nucleotide salvage Updated DEFINITION Any process that generates a pyridine nucleotide, a nucleotide characterized by a pyridine derivative as a nitrogen base, from deriviatives of them without de novo synthesis.
2004-02-06 GO:0009443 pyridoxal 5'-phosphate salvage Added DEFINITION Any process that generates pyridoxal 5'-phosphate, the active form of vitamin B6, from deriviatives of it without de novo synthesis.
2004-02-06 GO:0043100 pyrimidine nucleobase salvage Added DEFINITION Any process that generates pyrimidine bases, 1,3-diazine organic nitrogenous bases, from deriviatives of them without de novo synthesis.

Other

Timestamp GO ID GO Term Name Action Category Detail
2004-02-06 GO:0001806 type IV hypersensitivity Added SECONDARY GO:0016069 (delayed hypersensitivity response)
spacer
Please send comments, suggestions or bug reports to goa@ebi.ac.uk. Click here for details of how to cite UniProt-GOA and QuickGO.
115ms